Back to Search
Start Over
Real world outcomes of metastatic pancreatic cancer (mPC) patients (pts) treated with liposomal irinotecan (nal-IRI) in the US
- Source :
- Journal of Clinical Oncology. 36:e16229-e16229
- Publication Year :
- 2018
- Publisher :
- American Society of Clinical Oncology (ASCO), 2018.
-
Abstract
- e16229Background: The NAPOLI-1 study, a randomized phase 3 study in patients with mPDAC previously treated with gemcitabine-based therapy, demonstrated an improvement in overall survival (OS), prog...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
business.industry
Real world outcomes
Phases of clinical research
Gemcitabine
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Metastatic pancreatic cancer
medicine
Overall survival
Liposomal Irinotecan
In patient
Previously treated
business
030215 immunology
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........6726a8ae991c1d74e4e2dd3e3a303e4e